Diabetes and Endocrinology programme
|8am - 9am||Registration and Refreshments|
|9am - 9.10am||Welcome and Introduction by the Chair, Dr Tahseen Chowdhury|
|9.10am - 10.00am||
New treatments for diabetes with Professor Steven Gough
• Individualising glucose targets and therapy
|10.00am - 10.45am||
Current concepts in the prevention and management of diabetic foot disease with Dr Gerry Rayman
• Diabetic foot disease – the scale of the problem
|10.45am - 11.05am||Refreshments|
Monogenic Diabetes with Professor Graham Hitman
• How common is monogenic diabetes?
|11.50am - 12.30pm||
Managing the complexities of diabetes and renal disease with Dr Peter Winocour
• Managing diabetic patients with CKD
|12.30pm - 1.30pm||Lunch|
|1.30pm - 2.15pm||
Sponsored symposium supported by Eli Lilly and Company
Back to the future – insulin therapy in the 21st century with Professor David Russell-Jones
For information on how BMJ Masterclasses work with sponsors please see our sponsorship guidelines.
|2.15pm - 3.00pm||
An update on the prevention and management of osteoporosis with Professor Ali Jawad
• Screening for osteoporosis
|3.00pm - 3.20pm||Refreshments|
|3.20pm - 4.05pm||
Endocrine hypertension with Dr Mona Waterhouse
• How common are endocrine causes of hypertension
|4.05pm - 4.50pm||
Common calcium and sodium conundrums in clinical practice with Professor Will Drake
• Hyper- and hypocalcaemia
|4.50pm - 4.55pm||Summary and closing remarks|
Programme subject to change
Dr Tahseen Chowdhury
Consultant Physician and Diabetologist, Barts Health NHS Trust
Tahseen Chowdhury is a diabetes clinician in the department of diabetes and metabolism at the Royal London Hospital, in the East End of London. He runs a large specialist diabetes and metabolism unit, dealing with diabetes particularly among the Bangladeshi community of Tower Hamlets. Dr Chowdhury has a research and clinical interest in diabetes in South Asians, and has authored over 150 publications, including books entitled Diabetes in South Asian people: Explained and Diabetes Management in Clinical Practice. He qualified from the University of Birmingham and trained in Birmingham and Manchester, before becoming a consultant physician in 2000.
Gouveia CF, Chowdhury TA. Managing hyperglycaemic emergencies: an illustrative case and review of recent British guidelines. Clinical Med 2013;13:160-2
Chowdhury TA, Finer N. Preventing diabetes: a call for concerted national action. Clinical Med 2013; 13:328-9
Hull, SA, Chowdhury TA, Mathur R, Robson J. Improving outcomes for Type 2 diabetic patients by supporting general practice networks: a quality improvement project in East London. BMJ Qual and Saf 2013 Sep 3. doi: 10.1136/bmjqs-2013-002008.
Declaration of interests: None
Professor Ali Jawad
Consultant rheumatologist, The Royal London Hospital/WHRI QMUL
Professor Ali S M Jawad, MSc (Medical Immunology), FRCP (Lon, Ed, G) DCH, DMedRehab, is a Consultant Rheumatologist at Barts Health NHS Trust and Clinical Professor of Rheumatology at the William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London Since 2008, he has been Associate International Director (Middle East and North Africa) at RCP, International Development Lead at Barts Health and International Co-Chair at The British Society for Rheumatology. He has published widely: 3 books, chapters in several books and more than 120 articles in learned journals. He has won several grants, runs a metabolic bone service and is currently researching the role of RANK ligand in patients with RA and osteoporosis.
Mohammed M. Albogami, Ali S. Jawad, Rizgar A. Mageed . Bone loss in osteoporosis and arthritis. Pathogenesis and therapeutic strategies. Saudi Medical Journal2014; 35(3)
Declaration of interests: None
Dr Peter Winocour
Consultant Diabetologist and Clinical Director, East and North Herts NHS Trust
Peter Winocour is a consultant physician to the East and North Hertfordshire NHS Trust appointed in 1993. He has served as the Clinical Director for Diabetes and Endocrine services since 2008. He qualified in 1979 and received his M.D. degree from the University of Glasgow, and undertook further training in Manchester and Newcastle. Dr Wincour is a past Chairman of the Association of British Clinical Diabetologists and has coordinated national surveys of specialist diabetes services, and reported on the practical issues of meeting targets in the routine diabetes care, casting doubt on national and international guidelines. Dr. Winocour’s research interest in diabetes and endocrinology has resulted in publication of over 80 original articles . Currently he is coordinating joint ABCD-Renal Association guidelines on diabetic nephropathy. Dr Winocour was the Diabetes lead in the published JBS3 guidelines on CVD prevention. He is currently RCPL Secretary of the Joint Speciality Committee in Diabetes and Endocrinology and ABCD Lead on Transitional Diabetes Care.
Winocour PH . Care of adolescents and young adults with diabetes - much more than transitional care : a personal view . Clinical Medicine 2014:14:3 : 274-278
Declaration of interests: I have served on several pharmaceutical industry advisory boards including Jannsen , Astra Zeneca , BMS , Novo Nordisk , MSD and Takeda
Dr Gerry Rayman
Consultant Diabetologist, The Diabetes Centre, Ipswich Hospital
Dr Gerry Rayman is Head of Service at the Diabetes and Endocrine Centre, Ipswich Hospital. He has been NHSDiabetes’ clinical lead for the diabetic foot and national lead on inpatient diabetes care. He is the specialist medical advisor to DiabetesUK and clinical lead for their ‘Putting Feet First campaign’. He is the current President of the Endocrine and Diabetes section of the Royal Society of Medicine
Dr Rayman contributed to development of the National Diabetes Foot Audit, NCEPOD on amputations, and two NICE guidelines on the diabetic foot (CG10 and CG119).
Dr Rayman has been involved in organising conferences for DiabetesUK and the RSM and co-leads the Malvern international foot conference. He lectures nationally and internationally on the diabetic foot.
Cost of diabetic foot disease to the National Health Service in England. Kerr M, Rayman G, Jeffcoate WJ. Diabet Med. 2014 Jul 1
New national diabetes footcare audit of England and wales. Jeffcoate W, Holman N, Rayman G, Valabhji J, Young B. Diabet Med. 2014 Sep;31(9):1022-3
The Ipswich Touch Test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration. Sharma S, Kerry C, Atkins H, Rayman G. Diabet Med. 2014 Sep;31(9):1100-3.
Declaration of interests: none
Professor Graham Hitman
Blizard Institute Director and Professor of Molecular Medicine & Diabetes, Queen Mary University of London
Graham Hitman's main research interests are the genomics and the prevention of type 2 diabetes. He is the co-ordinator of an EU funded program, studying the gene environmental interaction in pregnancy and its relation to future cardiometabolic disease in the offspring in South Asian people. He is one of the principal investigators of the CARDS trial that has influenced the development of current lipid lowering guidelines in diabetes. He has over 250 peer-reviewed publications.
Declaration of interests: none
Professor Will Drake
Will Drake trained at the University of Oxford and the Royal London Hospital Medical College. After junior medical jobs in London and in Cape Town, South Africa, he returned to UK to specialise in Endocrinology at St Bartholomew’s Hospital. During his specialist registrar training and a laboratory research fellowship, he developed clinical research interests in the use of pegvisomant in acromegaly; and in the practice of GH replacement, both in adults and in adolescents. Following a 12 month medicine and endocrinology fellowship in Vancouver, Canada, he returned to the UK and now holds the position of Consultant Physician/Professor of Clinical Endocrinology at St Bartholomew’s Hospital.
Professor David Russell-Jones – symposium speaker
Professor of Diabetes & Endocrinology, Royal Surrey County Hospitals NHS Foundation Trust
David Russell-Jones qualified from Guy’s and St Thomas’ Hospital medical school in 1985. He did his SHO training in the ‘golden circle’ of famous London postgraduate institutions, including the Hammersmith, Brompton and Queens Square, before returning to St Thomas’ as registrar. He performed an MD under the direction of Professor Peter Sonksen.
He was appointed lecturer at Guy’s and St Thomas’ followed by Senior Lecturer and Consultant Physician in 1994. In 1998 he was appointed Professor of Diabetes and Endocrinology at the University of Surrey and Consultant Physician at the Royal Surrey County Hospital where he runs a full specialist diabetes and endocrine service for patients, including a large pituitary clinic. He is a full part of the general medical ‘take’ in addition to running specialist clinics and doing extensive research. He has recently been appointed by NHS England to be a member of the “Clinical Reference Group” for both specialist Endocrinology and specilaist Diabetes. His department has attracted large research grants and was rated 5*A in the recent university research assessment exercise.
Professor Russell-Jones raised £2 million and built an innovative ambulatory care and research centre, called the cedar centre, for patients with diabetes and endocrine disorders. He persuaded Sir Nicholas Grimshaw (of the Eden project and Waterloo International fame) to design the centre which was opened by Prince Andrew in 2005. The cedar centre was then donated to the NHS.
Further speaker biographies, recent publications and declarations will be uploaded in due course